
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
A recent survey found that US ob/gyn residents need more education about the benefits of the IUD in addition to evidence-based recommendations for IUD candidate selection.
A
POLL
Vote in the poll and share your comments with colleagues below.